Clinical usefulness of linked color imaging in identifying Helicobacter pylori infection: A systematic review and meta-analysis
- PMID: 38187911
- PMCID: PMC10768039
- DOI: 10.4253/wjge.v15.i12.735
Clinical usefulness of linked color imaging in identifying Helicobacter pylori infection: A systematic review and meta-analysis
Abstract
Background: Accurate diagnosis of Helicobacter pylori (H. pylori) infection status is a crucial premise for eradication therapy, as well as evaluation of risk for gastric cancer. Recent progress on imaging enhancement endoscopy (IEE) made it possible to not only detect precancerous lesions and early gastrointestinal cancers but also to predict H. pylori infection in real time. As a novel IEE modality, linked color imaging (LCI) has exhibited its value on diagnosis of lesions of gastric mucosa through emphasizing minor differences of color tone.
Aim: To compare the efficacy of LCI for H. pylori active infection vs conventional white light imaging (WLI).
Methods: PubMed, Embase, Embase and Cochrane Library were searched up to the end of April 11, 2022. The random-effects model was adopted to calculate the diagnostic efficacy of LCI and WLI. The calculation of sensitivity, specificity, and likelihood ratios were performed; symmetric receiver operator characteristic (SROC) curves and the areas under the SROC curves were computed. Quality of the included studies was chosen to assess using the quality assessment of diagnostic accuracy studies-2 tool.
Results: Seven original studies were included in this study. The pooled sensitivity, specificity, positive likelihood rate, and negative likelihood rate of LCI for the diagnosis of H. pylori infection of gastric mucosa were 0.85 [95% confidence interval (CI): 0.76-0.92], 0.82 (95%CI: 0.78-0.85), 4.71 (95%CI: 3.7-5.9), and 0.18 (95%CI: 0.10-0.31) respectively, with diagnostic odds ratio = 26 (95%CI: 13-52), SROC = 0.87 (95%CI: 0.84-0.90), which showed superiority of diagnostic efficacy compared to WLI.
Conclusion: Our results showed LCI can improve efficacy of diagnosis on H. pylori infection, which represents a useful endoscopic evaluation modality for clinical practice.
Keywords: Endoscopic diagnosis; Gastric cancer; Helicobacter pylori infection; Linked color imaging; Meta-analysis.
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures




Similar articles
-
The Diagnostic Performance of Linked Color Imaging Compared to White Light Imaging in Endoscopic Diagnosis of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.Gut Liver. 2024 May 15;18(3):444-456. doi: 10.5009/gnl230244. Epub 2023 Oct 6. Gut Liver. 2024. PMID: 37800315 Free PMC article.
-
Simultaneous detection of Helicobacter pylori infection comparing between white light and image-enhanced endoscopy.BMC Gastroenterol. 2024 Jan 26;24(1):46. doi: 10.1186/s12876-024-03132-y. BMC Gastroenterol. 2024. PMID: 38273222 Free PMC article.
-
Clinical significance and influencing factors of linked color imaging technique in real-time diagnosis of active Helicobacter pylori infection.Chin Med J (Engl). 2019 Oct 20;132(20):2395-2401. doi: 10.1097/CM9.0000000000000486. Chin Med J (Engl). 2019. PMID: 31651514 Free PMC article.
-
The role of linked color imaging in endoscopic diagnosis of Helicobacter pylori associated gastritis.Scand J Gastroenterol. 2020 Sep;55(9):1114-1120. doi: 10.1080/00365521.2020.1794025. Epub 2020 Jul 15. Scand J Gastroenterol. 2020. PMID: 32668999
-
Current status and future perspective of linked color imaging for gastric cancer screening: a literature review.J Gastroenterol. 2023 Jan;58(1):1-13. doi: 10.1007/s00535-022-01934-z. Epub 2022 Oct 26. J Gastroenterol. 2023. PMID: 36287268 Free PMC article. Review.
References
-
- Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19 Suppl 1:S37–S43. - PubMed
-
- Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M Japan Gast Study Group. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–397. - PubMed
-
- Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH. Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer. N Engl J Med. 2018;378:1085–1095. - PubMed
-
- Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology. 2016;150:1113–1124.e5. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous